Dyne Therapeutics’ stock sees record rally, but one analyst says it could still climb a lot further, after a rival got bought ...

Picard Medical's stock took a nosedive following a recent decision by the Tucson medical device company's shareholders.

A well-crafted narrative helps investors see not just the molecule in front of them, but the broader therapeutic and ...

MapLight Therapeutics Inc. shares jumped as much as 23% after the biotechnology firm raised $258.9 million in an initial ...

To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...

Akero Therapeutics CEO Andrew Cheng saved his company’s multibillion-dollar biotech deal with Novo Nordisk when it appeared ...

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Duopharma Biotech Berhad (KLSE:DPHARMA) as an investment opportunity by projecting its future cash ...

Dimitri Semenikhin, the retail trader behind the Beyond Meat stock rally is piling into a small biotech that recently pivoted ...

Editor’s Note: This deep dive was originally published Sept. 24, 2025, as a special edition of Biopharm Executive. Subscribe ...

China rivalry heats up, Chinese drugmakers are striking major deals with their global counterparts — including some in the ...

Genmab A/S (NASDAQ: GMAB) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Ram Selvaraju ...

The surge in biotech breeding has brought new scrutiny to how policies handle risk related to genetic manipulation. The ...